Penicillin allergy influences antibiotic selection due to potential cross-reactivity with which class, and what are plausible alternatives depending on infection?

• A. Cross-reactivity to cephalosporins; alternatives include macrolides or clindamycin depending on infection
• B. No cross-reactivity; cephalosporins are universally safe in penicillin-allergic patients
• C. Cross-reactivity to macrolides; alternatives include cephalosporins
• D. Vancomycin is the preferred alternative in all penicillin allergies

Answer: (B)

The main idea here is how penicillin allergy guides use of other antibiotics within the beta-lactam family and beyond. In practice, the concern is whether cephalosporins, which share the beta-lactam ring with penicillin, will trigger an allergic reaction. The commonly accepted view for many clinical scenarios is that cross-reactivity between penicillins and cephalosporins is low enough that cephalosporins can be used in most penicillin-allergic patients, especially with later-generation cephalosporins and in those without a history of severe penicillin anaphylaxis. This makes cephalosporins a viable alternative for treating many infections when a penicillin cannot be used.

If cephalosporins are not suitable due to patient history or infection type, other options can be chosen based on the organism and site of infection. For milder infections, macrolides or clindamycin are common alternatives; for broader Gram-positive or resistant organisms, doxycycline, fluoroquinolones, or, in serious cases or MRSA coverage, vancomycin may be used. The key is matching the drug spectrum to the infection while considering the patient’s allergy history.